FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law